Dillinct Dry Syrup 100ml, a pediatric cough formulation commonly used in Nigeria and other regions:
Dillinct Dry Syrup 100ml - Complete Pediatric Formulation Profile
šĀ Therapeutic Classification:
Antitussive + Antihistamine Combination (Pediatric)
ā
Ā Active Ingredients (per 5ml reconstituted):
-
Dextromethorphan HBr (7.5mg)Ā - Non-opioid cough suppressant
-
Diphenhydramine HCl (7.5mg)Ā - 1st-gen antihistamine
-
Phenylephrine HCl (2.5mg)Ā - Nasal decongestant
šÆĀ Primary Clinical Indications:
-
Dry, non-productive cough in children
-
Allergic cough
-
Post-nasal drip cough
-
Night-time cough suppression
-
Cold-related cough (6+ years)
šĀ Precision Pediatric Dosage:
-
Children 6-12 years:Ā 5ml every 6-8 hours (Max 20ml/24hrs)
-
Children 2-5 years:Ā 2.5ml every 6-8 hours (Max 10ml/24hrs)
-
Not recommendedĀ for infants below 2 years
-
Administration:Ā Use provided measuring cup
āļøĀ Pharmacokinetics:
ā ļøĀ Critical Contraindications:
šĀ Significant Interactions:
-
ā CNS depression with other sedatives
-
ā Sympathomimetic effects with stimulants
-
ā Anticholinergic effects with atropine-like drugs
-
Serotonin syndrome risk with SSRIs/SNRIs
šĀ Adverse Effect Profile:
-
Common: Mild drowsiness, dry mouth
-
Less common: Restlessness (paradoxical in some children), dizziness
-
Rare: Urinary retention, hallucinations (overdose)
š¬Ā Essential Monitoring:
š”Ā Key Administration Notes:
-
Reconstitution:Ā Add water to fill line (typically 80ml total volume)
-
Storage:Ā Refrigerate after reconstitution (discard after 14 days)
-
Best givenĀ at bedtime for nocturnal cough
-
Contains sucrose (caution in diabetes)
šĀ Clinical Alternatives:
-
Non-sedating:Ā Levodropropizine syrups
-
For chesty cough:Ā Carbocisteine syrups
-
Infant formula:Ā Pediatric Simple Linctus